Evidence map›Paper›PMID 31378555›Full record

Trial reportSchizophrenia research2019

Impact of first episode psychosis treatment on heavy cannabis use: Secondary analysis on RAISE-ETP study.

Karl C Alcover, Oladunni Oluwoye, Liat Kriegel, Sterling McPherson, Michael G McDonell

Abstract readLetterRandomized Controlled Trial
In one paragraph

Trial report in Schizophrenia research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Specialised early intervention teams for recent-onset psychosis.The Cochrane database of systematic reviews · 2020
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Karl C AlcoverBehavioral Health Innovations, Washington State University, Spokane, WA, United States of America.
Oladunni OluwoyeBehavioral Health Innovations, Washington State University, Spokane, WA, United States of America; Department of Medical Education and Clinical Sciences, Elson S. Floyd College of Medicine, Washington State University, Spokane, WA, United States of America. Electronic address: Oladunni.oluwoye@wsu.edu.
Liat KriegelBehavioral Health Innovations, Washington State University, Spokane, WA, United States of America.
Sterling McPhersonDepartment of Medical Education and Clinical Sciences, Elson S. Floyd College of Medicine, Washington State University, Spokane, WA, United States of America; Providence Medical Research Center, Providence Health Care, Spokane, WA, United States of America.
Michael G McDonellBehavioral Health Innovations, Washington State University, Spokane, WA, United States of America; Department of Medical Education and Clinical Sciences, Elson S. Floyd College of Medicine, Washington State University, Spokane, WA, United States of America.

Funding

Mentoring Emerging Scientists for Careers in Substance Use ResearchR25DA035163 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Carmen L Masson, Gideon St.Helen · 2014 to 2026
$4.6M
Novel EtG BasedContingency Management for Alcohol in the Severely Mentally IllR01AA020248 · NIAAA · WASHINGTON STATE UNIVERSITY · PI MCDONELL, MICHAEL G · 2012 to 2021
$4.6M
Improving Engagement among Families Experiencing First-Episode PsychosisK01MH117457 · NIMH · WASHINGTON STATE UNIVERSITY · PI OLUWOYE, OLADUNNI · 2019 to 2022
$667k
NIAAA NIH HHS R01 AA020248NIDA NIH HHS R25 DA035163NIMH NIH HHS K01 MH117457
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Employment, SupportedPatient Education as TopicAdolescentAdultAntipsychotic AgentsFamilyFemaleHumansMaleMarijuana AbuseMarijuana UseProportional Hazards ModelsPsychotic DisordersResilience, PsychologicalTreatment OutcomeYoung AdultAntipsychotic Agents

Identifiers

PMID31378555
PMCPMC6718318

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.